- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: cyclophosphamide, bortezomib and dexamethasone (CyBorD)
Total 470944 results
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
PharmaMarCompletedMultiple MyelomaSpain, France
-
Array Biopharma, now a wholly owned subsidiary...CompletedMultiple Myeloma, Plasma Cell LeukemiaUnited States
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
St. Jude Children's Research HospitalPfizerTerminatedAcute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia With Failed RemissionUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLCCompleted
-
Cancer Trials IrelandCompleted
-
TakedaWithdrawn
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Genzyme, a Sanofi Company; Millennium Pharmaceuticals...CompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Multiple MyelomaUnited States
-
Incyte CorporationTerminatedMetastatic Cancer | Solid Tumors | Advanced MalignanciesUnited States
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaGermany, Austria, Canada, Jordan, Norway, Sweden
-
CelgeneMultiple Myeloma Research ConsortiumCompleted
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
Pharmacyclics Switzerland GmbHJanssen Research & Development, LLCCompletedMultiple MyelomaSpain, Germany, Turkey, Greece, Italy, Czechia
-
BayerTerminatedMultiple MyelomaKorea, Republic of, Spain, United States
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Lymphoblastic LeukemiaUnited States, Australia, Canada, Brazil
-
Maimónides Biomedical Research Institute of CórdobaTerminated
-
Janssen Research & Development, LLCCompleted
-
National Cancer Institute (NCI)CompletedHead and Neck Cancer | Laryngeal Cancer | Oral Cancer | Carcinoma, Squamous | Pharyngeal CancerUnited States
-
University of Wisconsin, MadisonCompletedMantle Cell LymphomaUnited States
-
University of Wisconsin, MadisonMillennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)Millennium Pharmaceuticals, Inc.Withdrawn
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
Janssen Research & Development, LLCCompleted
-
Eli Lilly and CompanyCompletedMultiple MyelomaMexico, United States, Germany, Italy, France, Poland, Taiwan, Spain, Turkey, United Kingdom, Korea, Republic of, Greece, Canada, Brazil, Netherlands
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Children's Mercy Hospital Kansas CityMillennium Pharmaceuticals, Inc.TerminatedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Extranodal Marginal Zone Lymphoma of Mucosa-Associated... and other conditionsUnited States
-
St. Jude Children's Research HospitalNovartis Pharmaceuticals; Spectrum Pharmaceuticals, IncTerminatedAcute Lymphoblastic Leukemia | Leukemia, B-Cell | Leukemia, T-Cell | Lymphoma, Non-Hodgkin'sUnited States
-
Eli Lilly and CompanyCompleted
-
Janssen Pharmaceutical K.K.Completed
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Vejle HospitalThe University of Hong KongCompleted
-
University of ArkansasWithdrawn
-
Janssen Scientific Affairs, LLCCompletedMultiple MyelomaAustralia, China, Korea, Republic of
-
AB ScienceTerminatedMultiple MyelomaUnited States, France
-
City of Hope Medical CenterNational Cancer Institute (NCI)Withdrawn
-
Stanford UniversityNational Cancer Institute (NCI)CompletedB-cell Adult Acute Lymphoblastic Leukemia (ALL) | Ph-positive Adult Acute Lymphoblastic Leukemia (ALL) | Recurrent Adult Acute Lymphoblastic Leukemia (ALL) | T-cell Adult Acute Lymphoblastic Leukemia (ALL)United States
-
Massachusetts General HospitalCompletedMultiple MyelomaUnited States
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Oncology Specialists, S.C.Millennium Pharmaceuticals, Inc.TerminatedLymphoma, B-Cell | Lymphoma, Non-HodgkinUnited States
-
Mayo ClinicCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States